Correction to “Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing”

should be changed to "using assay by a fluorescence polarization immunoassay technique with a TDx/FLx analyzer (Abbott Diagnostics, Chicago, Illinois, U.S.A.)."

Publication Details

Journal
Cancer Medicine
Published
2026-02-01
DOI
https://doi.org/10.1002/cam4.71478
Primary Topic
Oral health in cancer treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction to “Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing”

Cancer Medicine
Oral health in cancer treatment
article

Correction to “Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing”

article en

Abstract

should be changed to "using assay by a fluorescence polarization immunoassay technique with a TDx/FLx analyzer (Abbott Diagnostics, Chicago, Illinois, U.S.A.)."

Cancer MedicineVol. 15(2)
Openalex Percentile: Top 63%
Oral health in cancer treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction to “Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing” · Cancer Medicine (2026) | TGRS Research Map | TGRS